These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36349258)

  • 1. Pyroptosis-Related Gene Signature Predicts the Prognosis of ccRCC Using TCGA and Single-Cell RNA Seq Database.
    Gan Y; Zhang Z; Wang X; Li A; Fan Y; Zhang Q
    J Healthc Eng; 2022; 2022():8224618. PubMed ID: 36349258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Predictive Model Based on Pyroptosis-Related Gene Features Can Effectively Predict Clear Cell Renal Cell Carcinoma Prognosis and May Be an Underlying Target for Immunotherapy.
    Wang Y; Liu J; Zhang L; Li Y
    Dis Markers; 2022; 2022():6402599. PubMed ID: 35845137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma.
    Fu L; Bao J; Li J; Li Q; Lin H; Zhou Y; Li J; Yan Y; Langston ME; Sun T; Guo S; Zhou X; Chen Y; Liu Y; Zhao Y; Lu J; Huang Y; Chen W; Chung BI; Luo J
    Front Immunol; 2022; 13():1021935. PubMed ID: 36248876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
    Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
    Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Pyroptosis-Related Prognostic Signature for Risk Stratification and Clinical Prognosis in Clear Cell Renal Cell Carcinoma.
    Pan XQ; Huang W; Jin LW; Lin HZ; Xu XY
    Dis Markers; 2022; 2022():8093837. PubMed ID: 35308143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma.
    Xia ZN; Wu JG; Yao WH; Meng YY; Jian WG; Wang TD; Xue W; Yu YP; Cai LC; Wang XY; Zhang P; Li ZY; Zhou H; Jiang ZC; Zhou JY; Zhang C
    Sci Rep; 2022 Jun; 12(1):10973. PubMed ID: 35768519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma.
    Li Z; Xia Z; Yu Y; Cai L; Jian W; Wang T; Xue W; Wang X; Wang B; Zhang P; Yao W; Zhang C; Wang C
    BMC Med Genomics; 2022 Sep; 15(1):204. PubMed ID: 36163033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyroptosis-Related Subtypes Predict the Response of Clear Cell Renal Cell Carcinoma to Targeted Therapy.
    Ma J; Kang Z; Yang G; Wang X; Si M; Wang Y; Li G; Bai S; Zeng F; Li M; Wang Z; Wang L; Xu W
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):334. PubMed ID: 38179741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma.
    Zhong M; Wang X; Zhu E; Gong L; Fei L; Zhao L; Wu K; Tang C; Zhang L; Wang Z; Zheng Z
    Front Genet; 2022; 13():905051. PubMed ID: 35846134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel model of pyroptosis-related molecular signatures for prognosis prediction of clear cell renal cell carcinoma patients.
    Chen J; Jiang R; Guan W; Cao Q; Tian Y; Dong K; Pan X; Cui X
    Int J Med Sci; 2024; 21(3):496-507. PubMed ID: 38250606
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma.
    Ju L; Shi Y; Liu G
    PeerJ; 2022; 10():e14506. PubMed ID: 36570012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
    Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
    Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma.
    Lu C; Wang Y; Nie L; Chen L; Li M; Qing H; Li S; Wu S; Wang Z
    Front Immunol; 2022; 13():934243. PubMed ID: 36189255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis.
    Yue Y; Cai X; Lu C; Sechi LA; Solla P; Li S
    Front Immunol; 2023; 14():1238312. PubMed ID: 37908350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic modification of PHLDA2 is associated with tumor microenvironment and unfavorable outcome of immune checkpoint inhibitor-based therapies in clear cell renal cell carcinoma.
    Zhao J; Pan X; Wang Z; Chen Y; Liu D; Shen Y; Wei X; Xu C; Zhang X; Hu X; Chen J; Zhao J; Tang B; Sun G; Shen P; Liu Z; Zeng H; Liang J
    Eur J Med Res; 2024 Jul; 29(1):378. PubMed ID: 39033192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the tumour microenvironment of clear cell renal cell carcinoma: Prognostic insights from programmed death genes using machine learning.
    Tu H; Hu Q; Ma Y; Huang J; Luo H; Jiang L; Zhang S; Jiang C; Lai H; Liu J; Chen J; Guo L; Yang G; Xu K; Chi H; Chen H
    J Cell Mol Med; 2024 Jul; 28(13):e18524. PubMed ID: 39011666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
    Gao J; Ye F; Han F; Jiang H; Zhang J
    Front Immunol; 2022; 13():956679. PubMed ID: 36177018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of pyroptosis-related subtypes and comprehensive analysis of characteristics of the tumor microenvironment infiltration in clear cell renal cell carcinoma.
    Zeng J; Zhu P; Tang Y; Zhang C; Ye C; Cheng S; Tian K; Yang B; Zeng W; Liu Y; Xian Z; Yu Y
    Sci Rep; 2023 Sep; 13(1):16055. PubMed ID: 37749171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database.
    Wan B; Liu B; Huang Y; Lv C
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1159. PubMed ID: 32012488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.